IDEXX Laboratories Inc
NASDAQ:IDXX

Watchlist Manager
IDEXX Laboratories Inc Logo
IDEXX Laboratories Inc
NASDAQ:IDXX
Watchlist
Price: 422.54 USD 1.16% Market Closed
Market Cap: 34.4B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+24%
Revenue
Forecast
+8%
Operating Income
Forecast
+12%
Net Income
Forecast
+13%

Wall Street
Price Targets

IDXX Price Targets Summary
IDEXX Laboratories Inc

Wall Street analysts forecast IDXX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IDXX is 522.8 USD with a low forecast of 410.16 USD and a high forecast of 594.3 USD.

IDXX Lowest Forecast
Wall Street Target
410.16 USD
3% Downside
IDXX Average Forecast
Wall Street Target
522.8 USD
24% Upside
IDXX Highest Forecast
Wall Street Target
594.3 USD
41% Upside
Lowest
Price Target
410.16 USD
3% Downside
Average
Price Target
522.8 USD
24% Upside
Highest
Price Target
594.3 USD
41% Upside
IDEXX Laboratories Inc Competitors:
Price Targets
S
300326
Shanghai Kinetic Medical Co Ltd
23% Downside
E
ELMD
Electromed Inc
60% Upside
CLPT
Clearpoint Neuro Inc
89% Upside
INMD
Inmode Ltd
19% Upside
S
300326
Shanghai Kinetic Medical Co Ltd
23% Downside
E
ELMD
Electromed Inc
60% Upside
CLPT
Clearpoint Neuro Inc
89% Upside
INMD
Inmode Ltd
19% Upside
7716
Nakanishi Inc
32% Upside
C
214150
Classys Inc
23% Upside
SN
Smith & Nephew PLC
18% Upside

Revenue
Forecast

Revenue Estimate
IDEXX Laboratories Inc

For the last 8 years the compound annual growth rate for IDEXX Laboratories Inc's revenue is 10%. The projected CAGR for the next 3 years is 8%.

10%
Past Growth
8%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
IDEXX Laboratories Inc

For the last 8 years the compound annual growth rate for IDEXX Laboratories Inc's operating income is 16%. The projected CAGR for the next 3 years is 12%.

16%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
IDEXX Laboratories Inc

For the last 8 years the compound annual growth rate for IDEXX Laboratories Inc's net income is 19%. The projected CAGR for the next 3 years is 13%.

19%
Past Growth
13%
Estimated Growth
Estimates Accuracy
7%
Average Beat
What are analyst estimates?

See Also

Summary
IDXX intrinsic value, competitors valuation, and company profile.
DCF Valuation
IDXX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
IDXX stock valuation using valuation multiples.
Wall Street Estimates
IDXX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
IDXX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IDXX's stock price target?
Price Target
522.8 USD

According to Wall Street analysts, the average 1-year price target for IDXX is 522.8 USD with a low forecast of 410.16 USD and a high forecast of 594.3 USD.

What is IDEXX Laboratories Inc's Revenue forecast?
Projected CAGR
8%

For the last 8 years the compound annual growth rate for IDEXX Laboratories Inc's revenue is 10%. The projected CAGR for the next 3 years is 8%.

What is IDEXX Laboratories Inc's Operating Income forecast?
Projected CAGR
12%

For the last 8 years the compound annual growth rate for IDEXX Laboratories Inc's operating income is 16%. The projected CAGR for the next 3 years is 12%.

What is IDEXX Laboratories Inc's Net Income forecast?
Projected CAGR
13%

For the last 8 years the compound annual growth rate for IDEXX Laboratories Inc's net income is 19%. The projected CAGR for the next 3 years is 13%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 241,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.